Biotech & MedTech News
-
Voyageur Pharmaceuticals Grants Deferred Share Units
July 9, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider…
-
Zentek Announces Grant of Stock Options
June 21, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN) announces the granting of options to acquire…
-
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
Bolsters Company’s Corporate Mission Financing Led by Board Member and Priced at Premium to Market Price June 20,…
-
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
June 11, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) announces that…
-
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
June 5, 2024 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
Coeptis Therapeutics’ Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting
May 30, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company developing…
-
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast
May 28, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) proudly announces…
-
Zentek Granted Second Patent from the Canadian Intellectual Patent Office
May 27, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization…
-
Zentek and DCL Supply Ltd. Sign Distribution Agreement for ZenGUARD Enhanced Air Filters
May 23, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company…
-
DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement
May 21, 2024 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
